SCHEMBL13820920

SCHEMBL13820920

CC1(C)c2ccccc2-c2cc3c(-c4ccc5ccccc5c4)c4cc(-c5ccccc5)ccc4c(-c4ccc(-c5cn6ccccc6n5)cc4)c3cc21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 10/20 0.41
▸ NPC1 O15118 9/20 0.41
▸ KDM4E B2RXH2 9/20 0.41
▸ PKM P14618 4/20 0.41
▸ EPHX2 P34913 1/20 0.41
▸ ALDH1A1 P00352 7/20 0.39
▸ SMN1; SMN2 Q16637 4/20 0.39
▸ MAPK1 P28482 2/20 0.39
▸ POLB P06746 2/20 0.38
▸ NFKB1 P19838 1/20 0.38
▸ NFKB2 Q00653 1/20 0.38
▸ RELA Q04206 1/20 0.38
▸ GFER P55789 3/20 0.38
▸ HDAC6 Q9UBN7 1/20 0.37
▸ PTGS1 P23219 1/20 0.37
▸ PTGS2 P35354 1/20 0.37
▸ KMT2A Q03164 3/20 0.36
▸ MEN1 O00255 2/20 0.36
▸ GAA P10253 1/20 0.36
▸ MIF P14174 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13820912 0.97 RAB9A (0.43) RAB9ANPC1KDM4EPKMEPHX2
SCHEMBL13820911 0.95 RAB9A (0.42) RAB9ANPC1KDM4EPKMEPHX2
SCHEMBL13820907 0.95 RAB9A (0.42) RAB9ANPC1KDM4EPKMEPHX2
SCHEMBL13820922 0.94 RAB9A (0.44) RAB9ANPC1KDM4EPKMEPHX2
SCHEMBL13820918 0.93 RAB9A (0.41) RAB9ANPC1KDM4EPKMEPHX2
SCHEMBL13820914 0.92 RAB9A (0.43) RAB9ANPC1KDM4EPKMEPHX2
SCHEMBL13820899 0.91 RAB9A (0.45) RAB9ANPC1KDM4EPKMEPHX2
SCHEMBL13820929 0.91 RAB9A (0.44) RAB9ANPC1KDM4EPKMEPHX2
SCHEMBL13820904 0.89 RAB9A (0.44) RAB9ANPC1KDM4EPKMEPHX2
SCHEMBL13820895 0.88 RAB9A (0.45) RAB9ANPC1KDM4EPKMEPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9012042-B2 Condensed-cyclic compound, organic light-emitting device comprising the same, and flat panel display apparatus SAMSUNG DISPLAY CO., LTD. (KR) 2015-04-21 — — US disclosed
US-9012042-B2 Condensed-cyclic compound, organic light-emitting device comprising the same, and flat panel display apparatus SAMSUNG DISPLAY CO., LTD. (KR) 2015-04-21 — — US disclosed
US-20120286246-A1 CONDENSED-CYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING THE SAME, AND FLAT PANEL DISPLAY APPARATUS SAMSUNG MOBILE DISPLAY CO., LTD. (KR) 2012-11-15 — — US disclosed
US-20120286246-A1 CONDENSED-CYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING THE SAME, AND FLAT PANEL DISPLAY APPARATUS SAMSUNG MOBILE DISPLAY CO., LTD. (KR) 2012-11-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120286246-A1 CONDENSED-CYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING THE SAME, AND FLAT PANEL DISPLAY APPARATUS OR10J3, AR, ARL1 RAB9A 1129/4885NPC1 2555/4885KDM4E 2875/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback